White Papers

1. Human-Centered RTSM Design Enhances Data, Safety, And Operations 12/5/2025

   Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.

2. Endpoint Clinical RTSM: Getting The Job Done 12/5/2025

   Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.

3. The Real Cost In CNS Trials: Rater Drift And Site Readiness 11/21/2025

   Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.

4. ICH GCP E6(R3) Implementation: Practical Approaches And Real-World Considerations 11/21/2025

   Access the full brief to learn how a phased, 12–18-month approach can help you meet ICH GCP E6(R3) requirements with confidence and avoid the costly pitfalls many organizations overlook.

5. Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials 11/21/2025

   This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.

6. The True ROI Of Decentralized Clinical Trials 11/13/2025

   Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

7. Retention Begins With Recruiting The Right-Fit Patients 11/13/2025

   Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.

8. 4 New Approvals In Q3 Across Gene, Cell, RNA Therapies 11/13/2025

   Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.

9. Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025) 11/7/2025

   Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.

10. The Answer To Your Pharmacovigilance Challenges: AI-Powered Adverse Event Detection 11/7/2025

    A proven, AI-powered safety platform can accelerate adverse event detection and safety data extraction to ease the burden on safety professionals and better protect patients.